These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related]
29. Arteriosclerosis risk in women and the role of oral contraceptive progestins. Knopp RH Int J Fertil; 1986; 31 SU [UPDATE]():20-30. PubMed ID: 2899556 [TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives and the risk of cardiovascular disease. Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850 [TBL] [Abstract][Full Text] [Related]
33. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism]. García L; Hernández I; Cervera Aguilar R; Ayala AR Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532 [TBL] [Abstract][Full Text] [Related]
35. Noncontraceptive estrogen use and cardiovascular disease. Bush TL; Barrett-Connor E Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919 [TBL] [Abstract][Full Text] [Related]
36. [How to choose an oral contraceptive in 1984]. Rozenbaum H Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609 [TBL] [Abstract][Full Text] [Related]